Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1948 1
1949 4
1950 4
1951 1
1952 3
1954 7
1955 1
1956 1
1957 4
1958 4
1959 2
1972 2
1973 1
1974 1
1975 1
1978 2
1980 2
1981 2
1982 1
1983 3
1984 2
1985 4
1986 9
1987 5
1988 2
1989 5
1990 6
1991 9
1992 3
1993 3
1994 7
1995 5
1996 9
1997 2
1998 6
1999 11
2000 12
2001 11
2002 12
2003 14
2004 21
2005 20
2006 8
2007 9
2008 18
2009 24
2010 28
2011 30
2012 29
2013 14
2014 10
2015 9
2016 6
2017 4
2018 5
2019 12
2020 5
2021 8
2022 10
2023 12
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Wong F, et al. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. N Engl J Med. 2021. PMID: 33657294 Clinical Trial.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team. Grant RM, et al. N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23. N Engl J Med. 2010. PMID: 21091279 Free PMC article. Clinical Trial.
Biomarkers for hepatocellular cancer.
Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Singh G, et al. Among authors: marquez v. World J Hepatol. 2020 Sep 27;12(9):558-573. doi: 10.4254/wjh.v12.i9.558. World J Hepatol. 2020. PMID: 33033565 Free PMC article. Review.
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas.
Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, Chen-Kiang S, Moscinski LC, Seto E, Dalton WS, Wright KL, Sotomayor E, Bhalla K, Tao J. Zhang X, et al. Among authors: marquez ve. Cancer Cell. 2023 Jun 12;41(6):1198. doi: 10.1016/j.ccell.2023.05.003. Cancer Cell. 2023. PMID: 37311416 Free article. No abstract available.
Review article: comprehensive analysis of cirrhotic cardiomyopathy.
Chahal D, Liu H, Shamatutu C, Sidhu H, Lee SS, Marquez V. Chahal D, et al. Among authors: marquez v. Aliment Pharmacol Ther. 2021 May;53(9):985-998. doi: 10.1111/apt.16305. Epub 2021 Mar 10. Aliment Pharmacol Ther. 2021. PMID: 33689169 Review.
Activation of Munc13-1 by Diacylglycerol (DAG)-Lactones.
Das J, You Y, Mathukumalli K, Ann J, Lee J, Marquez VE. Das J, et al. Among authors: marquez ve. Biochemistry. 2023 Sep 19;62(18):2717-2726. doi: 10.1021/acs.biochem.3c00375. Epub 2023 Aug 31. Biochemistry. 2023. PMID: 37651159
[Crohn's disease].
Márquez VR, Sanz M, Calderaro-di Ruggiero F, Daza Ramírez A, Casale Ochoa E, Márquez Atars I. Márquez VR, et al. G E N. 1989 Jul-Sep;43(3):209-13. G E N. 1989. PMID: 2535563 Review. Spanish.
Polycomb genes and cancer: time for clinical application?
Crea F, Paolicchi E, Marquez VE, Danesi R. Crea F, et al. Among authors: marquez ve. Crit Rev Oncol Hematol. 2012 Aug;83(2):184-93. doi: 10.1016/j.critrevonc.2011.10.007. Epub 2011 Nov 22. Crit Rev Oncol Hematol. 2012. PMID: 22112692 Review.
436 results